Aradhana Sasan

Array ( [id] => 8909001 [patent_doc_number] => 08481060 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Melt-coated pharmaceutical composition with fast release' [patent_app_type] => utility [patent_app_number] => 13/140585 [patent_app_country] => US [patent_app_date] => 2009-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8899 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 313 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13140585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7711802 [patent_doc_number] => 20120004163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'NUTRITIONAL COMPOSITION FOR INFANTS' [patent_app_type] => utility [patent_app_number] => 13/145042 [patent_app_country] => US [patent_app_date] => 2009-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5748 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13145042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9454724 [patent_doc_number] => 08715728 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-06 [patent_title] => 'Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof' [patent_app_type] => utility [patent_app_number] => 12/630271 [patent_app_country] => US [patent_app_date] => 2009-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 11514 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12630271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6478500 [patent_doc_number] => 20100092421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Process for the Preparation of Sevelamer Hydrochloride and Formulation Thereof' [patent_app_type] => utility [patent_app_number] => 12/620931 [patent_app_country] => US [patent_app_date] => 2009-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 9639 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092421.pdf [firstpage_image] =>[orig_patent_app_number] => 12620931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6087769 [patent_doc_number] => 20110217256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'CLEAR HAIR GEL FIXATIVES' [patent_app_type] => utility [patent_app_number] => 13/128423 [patent_app_country] => US [patent_app_date] => 2009-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4431 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217256.pdf [firstpage_image] =>[orig_patent_app_number] => 13128423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8875387 [patent_doc_number] => 08470345 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-25 [patent_title] => 'Lipids containing omega-3 and omega-6 fatty acids' [patent_app_type] => utility [patent_app_number] => 12/590893 [patent_app_country] => US [patent_app_date] => 2009-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 13295 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12590893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7697063 [patent_doc_number] => 20110229527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'DIRECTLY COMPRESSIBLE HIGH FUNCTIONALITY GRANULAR DIBASIC CALCIUM PHOSPHATE BASED CO-PROCESSED EXCIPIENT' [patent_app_type] => utility [patent_app_number] => 12/998655 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5350 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229527.pdf [firstpage_image] =>[orig_patent_app_number] => 12998655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6505679 [patent_doc_number] => 20100260844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'Oral pharmaceutical dosage forms' [patent_app_type] => utility [patent_app_number] => 12/590195 [patent_app_country] => US [patent_app_date] => 2009-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 39283 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260844.pdf [firstpage_image] =>[orig_patent_app_number] => 12590195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8532954 [patent_doc_number] => 08309107 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-13 [patent_title] => 'Stable solutions of orlistat for pharmaceutical dosage forms' [patent_app_type] => utility [patent_app_number] => 12/574215 [patent_app_country] => US [patent_app_date] => 2009-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7312 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12574215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9882009 [patent_doc_number] => 08968769 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-03 [patent_title] => 'Orally disintegrative dosage form' [patent_app_type] => utility [patent_app_number] => 12/566078 [patent_app_country] => US [patent_app_date] => 2009-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8163 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12566078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6546272 [patent_doc_number] => 20100016348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'ORALLY DISINTEGRATIVE DOSAGE FORM' [patent_app_type] => utility [patent_app_number] => 12/566096 [patent_app_country] => US [patent_app_date] => 2009-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8124 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016348.pdf [firstpage_image] =>[orig_patent_app_number] => 12566096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7773099 [patent_doc_number] => 08119166 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Methods of treatment using a gastric retained gabapentin dosage' [patent_app_type] => utility [patent_app_number] => 12/563781 [patent_app_country] => US [patent_app_date] => 2009-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 7256 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119166.pdf [firstpage_image] =>[orig_patent_app_number] => 12563781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7697158 [patent_doc_number] => 20110229432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'THERMOSENSITIVE COMPOSITION PREVENTING TISSUE ADHESION AND PREPARATION METHOD THEREOF' [patent_app_type] => utility [patent_app_number] => 13/129765 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4731 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229432.pdf [firstpage_image] =>[orig_patent_app_number] => 13129765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6569370 [patent_doc_number] => 20100234430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'METHODS AND PHARMACEUTICAL FORMULATIONS FOR PROTECTING PHARMACEUTICAL COMPOUNDS FROM ACIDIC ENVIRONMENTS' [patent_app_type] => utility [patent_app_number] => 12/558725 [patent_app_country] => US [patent_app_date] => 2009-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6284 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234430.pdf [firstpage_image] =>[orig_patent_app_number] => 12558725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7656493 [patent_doc_number] => 20110305762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING N-[3-CHLORO-4-[(3-FLUOROPHENYL)METHOXY]PHENYL]-6-[5[[[2-(METHYLSULFONYL)ETHYL]AMINO]METHYL]-2-FURYL]-4- QUINAZOLINAMINE' [patent_app_type] => utility [patent_app_number] => 13/060750 [patent_app_country] => US [patent_app_date] => 2009-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2738 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305762.pdf [firstpage_image] =>[orig_patent_app_number] => 13060750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 169902 [patent_doc_number] => 07662406 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-02-16 [patent_title] => 'Chewable softgel capsules' [patent_app_type] => utility [patent_app_number] => 12/543435 [patent_app_country] => US [patent_app_date] => 2009-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3575 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 345 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662406.pdf [firstpage_image] =>[orig_patent_app_number] => 12543435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8358690 [patent_doc_number] => 20120213846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration' [patent_app_type] => utility [patent_app_number] => 13/059154 [patent_app_country] => US [patent_app_date] => 2009-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15762 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13059154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6480531 [patent_doc_number] => 20100092548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'CHEWABLE SOFTGEL CAPSULES' [patent_app_type] => utility [patent_app_number] => 12/537092 [patent_app_country] => US [patent_app_date] => 2009-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3699 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092548.pdf [firstpage_image] =>[orig_patent_app_number] => 12537092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7499668 [patent_doc_number] => 20110262540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Solid Pharmaceutical Composition Comprising Exemestane' [patent_app_type] => utility [patent_app_number] => 13/054915 [patent_app_country] => US [patent_app_date] => 2009-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3289 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262540.pdf [firstpage_image] =>[orig_patent_app_number] => 13054915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9112605 [patent_doc_number] => 08568773 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Glycerophospholipids for the improvement of cognitive functions' [patent_app_type] => utility [patent_app_number] => 12/934338 [patent_app_country] => US [patent_app_date] => 2009-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9015 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12934338 [rel_patent_id] =>[rel_patent_doc_number] =>)